Search For "covaxin"
CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin,
Updated : 3 years, 7 months ago IST
New Delhi [India], August 10 (ANI): The Central government has approved Biological E's Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday.
Read More
Japan approves COVAXIN booster dose for travellers: Bharat Biotech
Updated : 3 years, 7 months ago IST
Hyderabad [Telangana], August 5 (ANI): Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers.
Read More
Covaxin booster dose increases immune response by 40 times, gives long-ter
Updated : 3 years, 8 months ago IST
Hyderabad (Telangana) [India], July 20 (ANI): Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against both
Read More
COVID-19 booster dose drive: UPHC Medical in-charge of Gaganmahal assures
Updated : 3 years, 8 months ago IST
Hyderabad (Telangana) [India], July 15 (ANI): Amid the ongoing 75 days COVID-19 booster dose drive, Urban Primary Health Centre's Medical in-charge of Gaganmahal, Hyderabad, Dr Raja Lakshmi said that the centres are having sufficient amount of stock of both Covishield and Covaxin.
Read More
NTAGI to discuss data of Gennova pharmaceuticals' indigenous mRNA vaccine
Updated : 3 years, 8 months ago IST
New Delhi [India], July 11 (ANI): The National Technical Advisory Group on Immunisation (NTAGI's) Covid working group is expected to conduct a meeting soon to discuss India's first mRNA vaccine against COVID and Biological E's Corbevax Booster dose for Covishield and Covaxin beneficiaries
Read More
NTAGI approves Corbevax, Covaxin for 5-12 yrs age group: Sources
Updated : 3 years, 8 months ago IST
New Delhi [India], July 8 (ANI): The National Technical Advisory Group on Immunisation's (NTAGI) Standing Technical Sub-Committee (STSC) has given a nod for the use of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between 5-12 years, sources informed on Friday.
Read More
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press
Read More
Covaxin booster shot enhances efficacy against Delta, Omicron variants of
Updated : 3 years, 9 months ago IST
New Delhi [India], June 15 (ANI): A study showed that administration of Covaxin booster dose will enhance the vaccine effectiveness against the Delta variant infection and give protection against two Omicron variants of COVID-19.
Read More
DCGI approves Corbevax as first heterologous COVID-19 booster shot for adu
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], June 4 (ANI): Biological E. Limited, a Hyderabad-based pharmaceutical and vaccines company, on Saturday, announced that its Corbevax COVID-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous COVID-19 booster dose for
Read More
Germany to recognize Bharat Biotech's COVAXIN for travel from June 1
Updated : 3 years, 10 months ago IST
New Delhi [India], May 26 (ANI): German Ambassador to India, Walter J Lindner, on Thursday hailed the German government for recognizing the WHO-listed Bharat Biotech's COVID vaccine, COVAXIN, for travel to the country starting June 1.
Read More
FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says
Updated : 3 years, 10 months ago IST
Malvern (Pennsylvania) [US], May 23 (ANI): Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold on the Company's Phase 2, 3 clinical trials for COVAXIN™ (BBV152).
Read More
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials i
Updated : 3 years, 10 months ago IST
New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.
Read More